Page last updated: 2024-08-16

3,3',4,5'-tetrahydroxystilbene and Carcinoma, Non-Small Cell Lung

3,3',4,5'-tetrahydroxystilbene has been researched along with Carcinoma, Non-Small Cell Lung in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tao, ZZ; Xu, B1
Jeong, JH; Kim, WY; Kim, Y; Lee, H; Ryu, JH1

Other Studies

2 other study(ies) available for 3,3',4,5'-tetrahydroxystilbene and Carcinoma, Non-Small Cell Lung

ArticleYear
Piceatannol Enhances the Antitumor Efficacy of Gemcitabine in Human A549 Non-Small Cell Lung Cancer Cells.
    Oncology research, 2014, Volume: 22, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; bcl-2 Homologous Antagonist-Killer Protein; bcl-Associated Death Protein; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Survival; Deoxycytidine; Dose-Response Relationship, Drug; Drug Synergism; Gemcitabine; Humans; Inhibitory Concentration 50; Lung Neoplasms; Stilbenes; Up-Regulation

2014
ATM/CHK/p53 Pathway Dependent Chemopreventive and Therapeutic Activity on Lung Cancer by Pterostilbene.
    PloS one, 2016, Volume: 11, Issue:9

    Topics: Antineoplastic Agents, Phytogenic; Ataxia Telangiectasia Mutated Proteins; Carcinoma, Non-Small-Cell Lung; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Checkpoint Kinase 1; Checkpoint Kinase 2; Humans; Lung Neoplasms; Proteome; Respiratory Mucosa; Resveratrol; Rheum; Signal Transduction; Stilbenes; Tumor Suppressor Protein p53

2016